ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	11/65	191/7206	8.73163333164e-07
ko04668	TNF signaling pathway	8/65	120/7206	1.06891217584e-05
ko04657	IL-17 signaling pathway	7/65	87/7206	1.15711334858e-05
ko04064	NF-kappa B signaling pathway	7/65	96/7206	2.21463512156e-05
ko05160	Hepatitis C	8/65	153/7206	6.22494893015e-05
ko04621	NOD-like receptor signaling pathway	8/65	157/7206	7.47440020141e-05
ko01522	Endocrine resistance	7/65	124/7206	0.000114728791376
ko05224	Breast cancer	7/65	174/7206	0.00090742581416
ko04658	Th1 and Th2 cell differentiation	5/65	96/7206	0.00166065807573
ko04650	Natural killer cell mediated cytotoxicity	5/65	97/7206	0.00173886304279
ko05200	Pathways in cancer	11/65	492/7206	0.00413887485072
ko05214	Glioma	4/65	79/7206	0.00546097912603
ko05168	Herpes simplex infection	6/65	182/7206	0.00574406400693
ko05131	Shigellosis	4/65	82/7206	0.00623061372349
ko05152	Tuberculosis	6/65	187/7206	0.00654112793695
ko05220	Chronic myeloid leukemia	4/65	85/7206	0.00706937656398
ko05167	Kaposi's sarcoma-associated herpesvirus infection	6/65	191/7206	0.00723469431571
ko04931	Insulin resistance	5/65	137/7206	0.00765236780742
ko04662	B cell receptor signaling pathway	4/65	88/7206	0.00797980173372
ko05222	Small cell lung cancer	4/65	89/7206	0.00829962398133
ko05219	Bladder cancer	3/65	48/7206	0.00907483405911
ko04062	Chemokine signaling pathway	6/65	201/7206	0.00920080879708
ko04810	Regulation of actin cytoskeleton	7/65	264/7206	0.00928156095256
ko05120	Epithelial cell signaling in Helicobacter pylori infection	4/65	92/7206	0.00930935015248
ko05205	Proteoglycans in cancer	7/65	271/7206	0.0106335189389
ko05146	Amoebiasis	4/65	99/7206	0.0119690732976
ko04620	Toll-like receptor signaling pathway	4/65	100/7206	0.0123848785062
ko01521	EGFR tyrosine kinase inhibitor resistance	4/65	106/7206	0.0150748606406
ko04012	ErbB signaling pathway	4/65	109/7206	0.0165482103315
ko05164	Influenza A	5/65	167/7206	0.0169935487675
ko05215	Prostate cancer	4/65	111/7206	0.0175790814951
ko05213	Endometrial cancer	3/65	62/7206	0.0181524780904
ko04330	Notch signaling pathway	3/65	62/7206	0.0181524780904
ko05221	Acute myeloid leukemia	3/65	63/7206	0.0189395761396
ko05206	MicroRNAs in cancer	5/65	177/7206	0.0213002933361
ko05223	Non-small cell lung cancer	3/65	66/7206	0.0214134614706
ko04932	Non-alcoholic fatty liver disease (NAFLD)	5/65	182/7206	0.0236995676921
ko04660	T cell receptor signaling pathway	4/65	124/7206	0.0252577349422
ko05145	Toxoplasmosis	4/65	126/7206	0.0265931581153
ko05134	Legionellosis	3/65	74/7206	0.0288377010392
ko05142	Chagas disease (American trypanosomiasis)	4/65	130/7206	0.0293899097769
ko04630	Jak-STAT signaling pathway	4/65	132/7206	0.0308516646102
ko04320	Dorso-ventral axis formation	2/65	31/7206	0.0314946991503
ko04072	Phospholipase D signaling pathway	5/65	197/7206	0.0319278451916
ko04380	Osteoclast differentiation	4/65	134/7206	0.0323559165548
ko05212	Pancreatic cancer	3/65	83/7206	0.0386198072955
ko05218	Melanoma	3/65	85/7206	0.0409964119982
ko05210	Colorectal cancer	3/65	86/7206	0.0422120136193
ko05323	Rheumatoid arthritis	3/65	89/7206	0.0459671510554
ko04920	Adipocytokine signaling pathway	3/65	89/7206	0.0459671510554